跳至主要内容
临床试验/NCT01383031
NCT01383031Unknown2 期

Randomized Controlled Trial Of Transumbilical Laparoendoscopic Single Site Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy

Beijing Friendship Hospital1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2010年10月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
入组人数
600
试验地点
1
主要终点
the incidence of surgical complications

研究概览

简要总结

The purpose of this study is to scientifically evaluate the safety, efficacy and cosmetic results of transumbilical laparoendoscopic single site cholecystectomy.

详细描述

As the natural orifice during embryonic, the transumbilical surgery not only can mask the abdominal scar and avoid infection produced by puncturing stomach, vagina or rectum in NOTES,but also can be played by the conventional laparoscopic instruments. TU-LESS (transumbilical laparoendoscopic single site surgery), is considered to be the most feasible NOTES(natural orifice transluminal endoscopic surgery)technology at present. Researches about TU-LESS mostly are case reports and small samples or the control experiments up to now,there are not persuasive randomized controlled trail between TU-LESS and conventional laparoscopic cholecystectomy. So the investigators design this prospective randomized controlled trail to scientifically evaluate the safety, efficacy and cosmetic results of transumbilical laparoendoscopic single site cholecystectomy .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •18 Years to 5 Years
  • •Benign gallbladder diseases
  • •informed consent

排除标准

  • •Obstructive jaundice
  • •Broadening of the common bile duct
  • •Gallstone pancreatitis
  • •Serious heart,brain,lung, metabolic diseases history
  • •History of upper abdominal surgery
  • •Pregnancy or breast-feeding women
  • •Refuse TU-LESSC
  • •BMI(Body Mass Index)≥ 30

研究组 & 干预措施

Laparoscopic Cholecystectomy

Active Comparator

Laparoscopic cholecystectomy(4 ports or 3 ports)will be performed in a routine fashion by one full time faculty member with fellowship training in laparoscopy.

干预措施: CLC (Procedure)

TU-LESSC

Active Comparator

TU-LESSC will be performed in a routine fashion which is same to CLC(conventional laparoscopic cholecystetomy)by one full time faculty member with fellowship training in laparoscopy through the conventional laparoscopic instruments.

干预措施: TU-LESSC (Procedure)

结局指标

主要结局

the incidence of surgical complications

时间窗: up to 12 weeks

The primary outcome messures are the incidence of surgical complications caused by the two surgeries.Bleeding,bile duct injury and bile leakage during operation.Wound infection,umbilical hernia,poke holes hernia and biliary fistula after operation.

次要结局

  • transfer rate(participants will be followed for the duration of hospital stay, an expected average of 5 days)
  • quality of life scores(up to 12 weeks)
  • pain scores(up to 12 weeks)
  • length of hospital stay(participants will be followed for the duration of hospital stay, an expected average of 5 days)
  • total cost of hospitalization(participants will be followed for the duration of hospital stay, an expected average of 5 days)
  • Cosmetic results(1 month)
  • The incidence of adverse events(up to 12 weeks)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验